145 related articles for article (PubMed ID: 11018454)
1. Nocardia brasiliensis: from microbe to human and experimental infections.
Salinas-Carmona MC
Microbes Infect; 2000 Sep; 2(11):1373-81. PubMed ID: 11018454
[TBL] [Abstract][Full Text] [Related]
2. Systemic increased immune response to Nocardia brasiliensis co-exists with local immunosuppressive microenvironment.
Salinas-Carmona MC; Rosas-Taraco AG; Welsh O
Antonie Van Leeuwenhoek; 2012 Oct; 102(3):473-80. PubMed ID: 22825801
[TBL] [Abstract][Full Text] [Related]
3. Nocardia brasiliensis cell wall lipids modulate macrophage and dendritic responses that favor development of experimental actinomycetoma in BALB/c mice.
Trevino-Villarreal JH; Vera-Cabrera L; Valero-Guillén PL; Salinas-Carmona MC
Infect Immun; 2012 Oct; 80(10):3587-601. PubMed ID: 22851755
[TBL] [Abstract][Full Text] [Related]
4. Construction of a Nocardia brasiliensis fluorescent plasmid to study Actinomycetoma pathogenicity.
Salinas-Carmona MC; Rocha-Pizaña MR
Plasmid; 2011 Jan; 65(1):25-31. PubMed ID: 20875450
[TBL] [Abstract][Full Text] [Related]
5. Experimental actinomycetoma due to Nocardia transvalensis in laboratory mice.
Unaogu IC; Gugnani HC; Ikerionwu SE
Mycoses; 1990 Feb; 33(2):99-102. PubMed ID: 2352546
[TBL] [Abstract][Full Text] [Related]
6. Immune response to Nocardia brasiliensis extracellular antigens in patients with mycetoma.
Castro-Matteotti B; Vera-Cabrera L; Ocampo-Candiani J; Rendón A; Salinas-Carmona MC; Welsh O
Mycopathologia; 2008 Mar; 165(3):127-34. PubMed ID: 18302006
[TBL] [Abstract][Full Text] [Related]
7. Physiological and pathogenic characteristics of Nocardia brasiliensis isolated from human mycetomas.
van Gelderen de Komaid A
Mycopathologia; 1989 Feb; 105(2):111-6. PubMed ID: 2747785
[TBL] [Abstract][Full Text] [Related]
8. Immune response to Nocardia brasiliensis antigens in an experimental model of actinomycetoma in BALB/c mice.
Salinas-Carmona MC; Torres-Lopez E; Ramos AI; Licon-Trillo A; Gonzalez-Spencer D
Infect Immun; 1999 May; 67(5):2428-32. PubMed ID: 10225905
[TBL] [Abstract][Full Text] [Related]
9. Mycetoma caused by Nocardia brasiliensis in an immunocompetent patient.
Sousa JM; Wachholz PA; Sette CS; Marques GF; Barreto JA
J Dtsch Dermatol Ges; 2014 Oct; 12(10):903-5. PubMed ID: 25135693
[No Abstract] [Full Text] [Related]
10. Nocardia harenae, an uncommon causative organism of mycetoma: report on two patients.
Kresch-Tronik NS; Carrillo-Casas EM; Arenas R; Atoche C; Ochoa-Carrera LA; Xicohtencatl-Cortes J; Manjarrez-Hernández ÁH; Hernández-Castro R
J Med Microbiol; 2012 Aug; 61(Pt 8):1153-1155. PubMed ID: 22499778
[TBL] [Abstract][Full Text] [Related]
11. Actinomycetoma in arm disseminated to lung with grains of Nocardia brasiliensis with peripheral filaments.
Muñoz-Hernández B; Noyola MC; Palma-Cortés G; Rosete DP; Galván MA; Manjarrez ME
Mycopathologia; 2009 Jul; 168(1):37-40. PubMed ID: 19238584
[TBL] [Abstract][Full Text] [Related]
12. Genomic Changes Associated with the Loss of Nocardia brasiliensis Virulence in Mice after 200 In Vitro Passages.
Gonzalez-Carrillo C; Millan-Sauceda C; Lozano-Garza HG; Ortiz-Lopez R; Elizondo-Gonzalez R; Welsh O; Ocampo-Candiani J; Vera-Cabrera L
Infect Immun; 2016 Sep; 84(9):2595-606. PubMed ID: 27354446
[TBL] [Abstract][Full Text] [Related]
13. Nocardial infection of the skin.
Hay RJ
J Hyg (Lond); 1983 Dec; 91(3):385-91. PubMed ID: 6363524
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase blockade with aminoguanidine, protects mice infected with Nocardia brasiliensis from actinomycetoma development.
Salinas-Carmona MC; Longoria-Lozano O; Garza-Esquivel HR; López-Ulloa J; Reyes-Carrillo J; Vázquez-Marmolejo AV
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008775. PubMed ID: 33091049
[TBL] [Abstract][Full Text] [Related]
15. Nocardia brasiliensis: mycetoma induction and growth cycle.
Conde C; Melendro EI; Fresán M; Ortiz-Ortiz L
Infect Immun; 1982 Dec; 38(3):1291-5. PubMed ID: 7152671
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis.
Espinoza-González NA; Welsh O; de Torres NW; Cavazos-Rocha N; Ocampo-Candiani J; Said-Fernandez S; Lozano-Garza G; Choi SH; Vera-Cabrera L
Molecules; 2008 Jan; 13(1):31-40. PubMed ID: 18259127
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice.
Chacon-Moreno BE; Welsh O; Cavazos-Rocha N; de la Luz Salazar-Cavazos M; Garza-Lozano HG; Said-Fernandez S; Ocampo-Candiani J; Vera-Cabrera L
Antimicrob Agents Chemother; 2009 Jan; 53(1):295-7. PubMed ID: 18852277
[TBL] [Abstract][Full Text] [Related]
18. [Immunoglobulins in patients with Nocardia brasiliensis actinomycetoma].
Méndez-Tovar LJ; Mondragón-González R; Manzano-Gayosso P; López-Martínez R; Hernández-Hernández F; Bonifaz A; Anides Fonseca A; Araiza J; Vega-López F
Rev Argent Microbiol; 2004; 36(4):174-8. PubMed ID: 15786870
[TBL] [Abstract][Full Text] [Related]
19. Resistance to Nocardia brasiliensis infection in mice immunized with either Nocardia or BCG.
Ximénez C; Melendro EI; González-Mendoza A; García AM; Martínez A; Ortiz-Ortiz L
Mycopathologia; 1980 Mar; 70(2):117-22. PubMed ID: 7393313
[TBL] [Abstract][Full Text] [Related]
20. In situ TLR2 and TLR4 expression in a murine model of mycetoma caused by Nocardia brasiliensis.
Millán-Chiu BE; Hernández-Hernández F; Pérez-Torres A; Méndez-Tovar LJ; López-Martínez R
FEMS Immunol Med Microbiol; 2011 Apr; 61(3):278-87. PubMed ID: 21205004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
